Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Vaccines

  Free Subscription


23.12.2024

1 Ann Intern Med
1 Arch Pediatr
2 Arch Virol
1 BMC Pediatr
2 BMJ
5 Clin Infect Dis
1 Indian Pediatr
1 Infect Immun
2 J Infect
5 J Infect Dis
2 JAMA
1 Lancet
2 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
2 Pediatr Infect Dis J
2 Pediatrics
7 PLoS One
2 Proc Natl Acad Sci U S A
1 Science
49 Vaccine
2 Virology
2 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Intern Med

  1. VASSILOPOULOS S, Mylonakis E
    After COVID-19 diagnosis, risk for incident type 2 diabetes was elevated for up to 2 y.
    Ann Intern Med. 2024 Dec 3. doi: 10.7326/ANNALS-24-02887.
    PubMed         Abstract available


    Arch Pediatr

  2. MORTENSEN GL, Charkaluk ML
    Parental knowledge about respiratory syncytial virus and attitudes toward infant immunization with monoclonal antibodies in France.
    Arch Pediatr. 2024 Sep 10:S0929-693X(24)00137.
    PubMed         Abstract available


    Arch Virol

  3. SORDO-PUGA Y, Santana-Rodriguez E, Perez-Perez D, Mendez-Orta MK, et al
    Porvac((R)) subunit vaccine induces neutralizing antibodies against all three main classical swine fever virus genotypes.
    Arch Virol. 2024;170:22.
    PubMed         Abstract available

  4. OLORUNTIMEHIN ES, Volodina SI, Patraman IV, Nadtochey GA, et al
    Molecular and ultrastructural characteristics of virulent and attenuated vaccine strains of goose parvovirus LIV-22.
    Arch Virol. 2024;170:4.
    PubMed         Abstract available


    BMC Pediatr

  5. LESHEM E, Malone S, Solsrud A, Dodd S, et al
    Pediatric providers' views on participating in an HPV Vaccine Quality Improvement Intervention: a qualitative analysis.
    BMC Pediatr. 2024;24:824.
    PubMed         Abstract available


    BMJ

  6. PATERLINI M
    Italy abolishes fines for refusing covid-19 vaccination.
    BMJ. 2024;387:q2833.
    PubMed        

  7. FLATT A, Vivancos R, French N, Quinn S, et al
    Inequalities in uptake of childhood vaccination in England, 2019-23: longitudinal study.
    BMJ. 2024;387:e079550.
    PubMed         Abstract available


    Clin Infect Dis

  8. BERTHAUD V, Creech CB, Rostad CA, Carr Q, et al
    Safety and Immunogenicity of an mRNA-1273 Booster in Children.
    Clin Infect Dis. 2024 Aug 19:ciae420. doi: 10.1093.
    PubMed         Abstract available

  9. TENFORDE MW, Reeves EL, Weber ZA, Tartof SY, et al
    Influenza vaccine effectiveness against hospitalizations and emergency department or urgent care encounters for children, adolescents, and adults during the 2023-2024 season, United States.
    Clin Infect Dis. 2024 Dec 4:ciae597. doi: 10.1093.
    PubMed         Abstract available

  10. WEE LE, Lim JT, Goel M, Malek MIA, et al
    Bivalent boosters and risk of post-acute sequelae following vaccine-breakthrough SARS-CoV-2 Omicron infection: a cohort study.
    Clin Infect Dis. 2024 Dec 5:ciae598. doi: 10.1093.
    PubMed         Abstract available

  11. DAGAN R, van der Beek BA
    Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine is Reduced in Infants Immunized during the Respiratory Viral Season.
    Clin Infect Dis. 2024 Dec 17:ciae619. doi: 10.1093.
    PubMed         Abstract available

  12. WANG X, Patel C, Giles ML, Burns P, et al
    Glucocorticoid dosing and implications for vaccination: Evolution of global definitions.
    Clin Infect Dis. 2024 Dec 18:ciae613. doi: 10.1093.
    PubMed         Abstract available


    Indian Pediatr

  13. DHARMAPALAN D, Gavhane J, Patil A, Shahane S, et al
    Mumps Epidemic in Navi Mumbai in 2023-24: Lessons for the Health Management System.
    Indian Pediatr. 2024;61:1123-1126.
    PubMed         Abstract available


    Infect Immun

  14. HALDAR R, Halder P, Koley H, Miyoshi S-i, et al
    A newly developed oral infection mouse model of shigellosis for immunogenicity and protective efficacy studies of a candidate vaccine.
    Infect Immun. 2024 Dec 18:e0034624. doi: 10.1128/iai.00346.
    PubMed         Abstract available


    J Infect

  15. MOK CKP, Tang YS, Tan CW, Chong KC, et al
    Comparison of safety and immunogenicity in the elderly after receiving either Comirnaty or Spikevax monovalent XBB1.5 COVID-19 vaccine.
    J Infect. 2024;90:106374.
    PubMed         Abstract available

  16. BORROW R, Campbell H, Caugant DA, Cherkaoui A, et al
    Global Meningococcal Initiative: Insights on antibiotic resistance, control strategies and advocacy efforts in Western Europe.
    J Infect. 2024;89:106335.
    PubMed         Abstract available


    J Infect Dis

  17. HOY G, Stadlbauer D, Balmaseda A, Kuan G, et al
    Humoral correlates of protection against influenza A H3N2 virus infection.
    J Infect Dis. 2024 May 9:jiae258. doi: 10.1093.
    PubMed         Abstract available

  18. CHAN JCH, Leung D, Chan SM, Tam IYS, et al
    Seroepidemiology of Measles and Rubella Among Hong Kong Young Adults and the Humoral Responses of a Measles-Mumps-Rubella Booster Among Participants With Low Antibody Levels.
    J Infect Dis. 2024;230:1367-1375.
    PubMed         Abstract available

  19. ATMAR RL, Ettayebi K, Neill FH, Braun RP, et al
    Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen-Blocking Antibody Levels.
    J Infect Dis. 2024;230:1376-1379.
    PubMed         Abstract available

  20. HAMMERTON SM, Billings WZ, Hemme H, Ross TM, et al
    Estimating standard-dose and high-dose Fluzone vaccine efficacies for influenza A based on HAI titers.
    J Infect Dis. 2024 Dec 13:jiae615. doi: 10.1093.
    PubMed         Abstract available

  21. FORCADELL-PERIS MJ, Vila-Corcoles A, de Diego-Cabanes C, Torras Vives V, et al
    Evaluating Sex Differences in Pneumococcal Disease Burden and Vaccination Effectiveness in Adults: A Population-Based Study.
    J Infect Dis. 2024 Dec 16:jiae624. doi: 10.1093.
    PubMed         Abstract available


    JAMA

  22. RUBIN R
    In Search of COVID-19 Vaccines That Elicit Mucosal Immunity and Stop Transmission.
    JAMA. 2024 Dec 20. doi: 10.1001/jama.2024.23627.
    PubMed        

  23. ANDERER S
    Trial Shows It's Safe to Get COVID-19, Flu Vaccines at the Same Time.
    JAMA. 2024 Dec 13. doi: 10.1001/jama.2024.24891.
    PubMed        


    Lancet

  24. TONY YANG Y
    The perils of RFK Junior's anti-vaccine leadership for public health.
    Lancet. 2024 Dec 18:S0140-6736(24)02603-5. doi: 10.1016/S0140-6736(24)02603.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  25. SCHILLIE S, Loehr J, Chen WH, Moser CA, et al
    New Dosing Interval and Schedule for the Bexsero MenB-4C Vaccine: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, October 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:1124-1128.
    PubMed         Abstract available

  26. HARDY CM, Rathee M, Chaudhury S, Wadood MZ, et al
    Progress Toward Poliomyelitis Eradication - Afghanistan, January 2023-September 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:1129-1134.
    PubMed         Abstract available


    N Engl J Med

  27. MUYEMBE JJ, Pan H, Peto R, Diallo A, et al
    Ebola Outbreak Response in the DRC with rVSV-ZEBOV-GP Ring Vaccination.
    N Engl J Med. 2024;391:2327-2336.
    PubMed         Abstract available


    Pediatr Infect Dis J

  28. PLOTKIN SA
    Do We Need a Lyme Disease Vaccine?
    Pediatr Infect Dis J. 2025;44:32.
    PubMed        

  29. BURTON C, Webb R, Anglemyer A, Humphrey A, et al
    Severe Invasive Pneumococcal Disease Caused by Serotype 19A in Children Under Five Years in Tamaki Makaurau Auckland, Aotearoa New Zealand.
    Pediatr Infect Dis J. 2025;44:90-96.
    PubMed         Abstract available


    Pediatrics

  30. ZALOT MA, Cortese MM, O'Callaghan KP, Casey-Moore MC, et al
    Risk of Transmission of Vaccine-Strain Rotavirus in a Neonatal Intensive Care Unit That Routinely Vaccinates.
    Pediatrics. 2024 Dec 9:e2024067621. doi: 10.1542/peds.2024-067621.
    PubMed         Abstract available

  31. SANDORA TJ
    Rotavirus Vaccination in the NICU: It's Time to Turn Opportunity Into Action.
    Pediatrics. 2024 Dec 9:e2024068248. doi: 10.1542/peds.2024-068248.
    PubMed        


    PLoS One

  32. NAULLY PG, Tan MI, Nugrahapraja H, Artarini AA, et al
    Design of multi-epitope-based therapeutic vaccine candidates from HBc and HBx proteins of hepatitis B virus using reverse vaccinology and immunoinformatics approaches.
    PLoS One. 2024;19:e0313269.
    PubMed         Abstract available

  33. D'SOUZA GC, Yingst JM, Krebs NM, Bordner C, et al
    Using the diffusion of innovations theory to understand factors associated with COVID-19 vaccination among tobacco users.
    PLoS One. 2024;19:e0309780.
    PubMed         Abstract available

  34. ZHENG J, Li B, Jia L, Zhang J, et al
    Tumorigenicity decrease in Bcl-xL deficient MDCK cells ensuring the safety for influenza vaccine production.
    PLoS One. 2024;19:e0311069.
    PubMed         Abstract available

  35. BEISSEGULOVA G, Ramazanova B, Mustafina K, Begadilova T, et al
    Prevalence of nasopharyngeal Streptococcus Pneumoniae carriage in infants: A systematic review and meta-analysis of cohort studies and randomized controlled trials.
    PLoS One. 2024;19:e0315461.
    PubMed         Abstract available

  36. EDOSSA ZK, Erchafo Lubago B, Baye MF, Alemu RK, et al
    Vaccination card loss and associated factors in Ethiopia: A multilevel analysis using Ethiopia Mini Demographic and Health Survey 2019 data.
    PLoS One. 2024;19:e0311925.
    PubMed         Abstract available


  37. Correction: Vaccination against misinformation: The inoculation technique reduces the continued influence effect.
    PLoS One. 2024;19:e0316311.
    PubMed         Abstract available

  38. GUERRERIO AL, Mateja A, MacCarrick G, Fintzi J, et al
    Cardiovascular complications in vascular connective tissue disorders after COVID-19 infection and vaccination.
    PLoS One. 2024;19:e0315499.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  39. MEHRA S, Nosten F, Luxemburger C, White NJ, et al
    Modeling the within-host dynamics of Plasmodium vivax hypnozoite activation: An analysis of the SPf66 vaccine trial.
    Proc Natl Acad Sci U S A. 2024;121:e2401024121.
    PubMed         Abstract available


  40. Correction for Mehmood et al., Teacher vaccinations enhance student achievement in Pakistan: The role of role models and theory of mind.
    Proc Natl Acad Sci U S A. 2025;122:e2424809121.
    PubMed        


    Science

  41. MALLAJOSYULA V, Chakraborty S, Sola E, Fong RF, et al
    Coupling antigens from multiple subtypes of influenza can broaden antibody and T cell responses.
    Science. 2024;386:1389-1395.
    PubMed         Abstract available


    Vaccine

  42. POSTON TB, Girardi J, Kim M, Zwarycz P, et al
    Intranasal immunization with CPAF combined with ADU-S100 induces an effector CD4 T cell response and reduces bacterial burden following intravaginal infection with Chlamydia muridarum.
    Vaccine. 2025;43.
    PubMed         Abstract available

  43. LANG BALIJA M, Jagusic M, Forcic D, Ivancic-Jelecki J, et al
    Mumps virus neurovirulence assessment-impact of viral doses, animal sex and age on results dispersion.
    Vaccine. 2025;43.
    PubMed         Abstract available

  44. CHAUDHARY M, Cutland CL, Bonet M, Gentile A, et al
    Burden of Lassa fever disease in pregnant women and children and options for prevention.
    Vaccine. 2025;43.
    PubMed         Abstract available

  45. SANCHEZ-MARTINEZ ZV, Alpuche-Lazcano SP, Stuible M, Akache B, et al
    SARS-CoV-2 spike-based virus-like particles incorporate influenza H1/N1 antigens and induce dual immunity in mice.
    Vaccine. 2024;42:126463.
    PubMed         Abstract available

  46. MOUSTAFA DA, Lou E, Schafer-Kestenman ME, Mateu-Borras M, et al
    Pseudomonas aeruginosa elongation factor-Tu (EF-Tu) is an immunogenic protective protein antigen.
    Vaccine. 2024;42:126476.
    PubMed         Abstract available

  47. TANG A, Zhu M, Zhu J, Zhang D, et al
    The recombinant feline herpesvirus 1 expressing feline Calicivirus VP1 protein is safe and effective in cats.
    Vaccine. 2024;42:126468.
    PubMed         Abstract available

  48. SILVA HM
    Return of poliomyelitis: A real risk in a country afflicted by scientific denialism.
    Vaccine. 2025;44:126449.
    PubMed         Abstract available

  49. TRAVILL DI, Machalek DA, Rees H, Mbulawa Z, et al
    High prevalence of human papillomavirus (HPV) in unvaccinated adolescent girls in South Africa, particularly those living with HIV.
    Vaccine. 2024;42:126442.
    PubMed         Abstract available

  50. TONG K, Hernandez EM, Basore K, Fremont DH, et al
    Chikungunya virus E2 B domain nanoparticle immunogen elicits homotypic neutralizing antibody in mice.
    Vaccine. 2024;42:126405.
    PubMed         Abstract available

  51. WU R, Chen Z, Yang X, Chen Y, et al
    Investigating the characteristics of mumps outbreaks in Fujian Province, China.
    Vaccine. 2024;42:126415.
    PubMed         Abstract available

  52. KANG S, Chung E, Hong C, Aziz AB, et al
    Raising the case of hepatitis E: Report from the 2nd international HEV symposium.
    Vaccine. 2024;42:126398.
    PubMed         Abstract available

  53. FOTAKIS EA, Picasso E, Sacco C, Petrone D, et al
    Impact of the 2023/24 autumn-winter COVID-19 seasonal booster campaign in preventing severe COVID-19 cases in Italy (October 2023-March 2024).
    Vaccine. 2024;42:126375.
    PubMed         Abstract available

  54. PRY JM, McCullough K, Lai KW, Lim E, et al
    Defining long COVID using a population-based SARS-CoV-2 survey in California.
    Vaccine. 2024;42:126358.
    PubMed         Abstract available

  55. WADA YA, Mazlan M, Noordin MM, Mohd-Lila MA, et al
    Rabies epidemiology in Malaysia (2015-2023): A cross-sectional insights and strategies for control.
    Vaccine. 2024;42:126371.
    PubMed         Abstract available

  56. CHUN J, Yoon D, Nowakowska A, Lee HD, et al
    Delivery of SARS-CoV-2 spike and membrane genes in a single Baculoviral vector enhance the immune breadth against SARS-CoV-2 variants of concern.
    Vaccine. 2024;42:126355.
    PubMed         Abstract available

  57. CANETTI M, Barda N, Lustig Y, Weiss-Ottolenghi Y, et al
    Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workers.
    Vaccine. 2024;42:126308.
    PubMed         Abstract available

  58. SUN JW, Dodge LE, Kim EJ, Zhou L, et al
    Risk of adverse events after Omicron XBB-adapted BNT162b2 COVID-19 vaccination in the United States.
    Vaccine. 2024;45:126629.
    PubMed         Abstract available

  59. SINGER R, Hubotter I, Holzner F, Genedl C, et al
    School vaccination programmes to increase HPV vaccination coverage - Experiences from Bremen, Germany.
    Vaccine. 2024;45:126636.
    PubMed         Abstract available

  60. MOGHTADERI A, Callaghan T, Luo Q, Motta M, et al
    Evidence on trends in uptake of childhood vaccines and association with COVID-19 vaccination rates.
    Vaccine. 2024;45:126631.
    PubMed         Abstract available

  61. BIAN S, Cai Q, Wang S, Xie Y, et al
    Evaluation of the toxoplasma Urm1 gene deletion mutant (PruDeltaUrm1) as a promising vaccine candidate against toxoplasmosis in mice.
    Vaccine. 2024;45:126632.
    PubMed         Abstract available

  62. NUZHATH T, Yang Y, Couture MC, Gu NY, et al
    Structural equation modeling to evaluate the adult vaccine hesitancy scale for vaccines recommended during pregnancy.
    Vaccine. 2024;45:126568.
    PubMed         Abstract available

  63. YANG J, Yao YL, Lv XY, Geng LH, et al
    The Safety and Efficacy of inactivated COVID-19 vaccination in couples undergoing assisted reproductive technology: A prospective cohort study.
    Vaccine. 2024;45:126635.
    PubMed         Abstract available

  64. DE OLIVEIRA LA, de Morais IRB, Marchioro SB, de Almeida GB, et al
    Corrigendum to Assessment of the Bnt162b2 covid-19 vaccine immune response in Brazilian indigenous adolescents. Vaccine Volume 43, Part 1, 1 January 2025, 126494.
    Vaccine. 2024;45:126630.
    PubMed        

  65. KASSAM P, El-Zein M, Tota JE, Tellier PP, et al
    HPV vaccination and anal HPV infection in gay, bisexual, and other men who have sex with men.
    Vaccine. 2024;45:126644.
    PubMed         Abstract available

  66. PERRIER Q, Noble J, Bonadona A, Augier C, et al
    Timing of rejection events preceded by Covid-19 mRNA vaccination in recipients of solid organ transplants.
    Vaccine. 2024;45:126617.
    PubMed         Abstract available

  67. WILLIAMS JTB, Ritger C, Holliman BD, Huebschmann AG, et al
    Staff and caregivers' perceptions of digital storytelling to increase influenza vaccine confidence in an urban safety-net healthcare system.
    Vaccine. 2024;45:126572.
    PubMed         Abstract available

  68. LIMA JLC, da Silva AB, Cabral AS, de Miranda FM, et al
    Changes in population genetic structure of serotype 19A Streptococcus pneumoniae after universal childhood use of the 10-valent pneumococcal conjugate vaccine in Brazil.
    Vaccine. 2024;45:126588.
    PubMed         Abstract available

  69. BAINBRIDGE S, Mappi T, Cleaveland S, Chubwa C, et al
    Field vaccination of locally-owned cattle against malignant catarrhal fever under environmentally challenging conditions in Tanzania.
    Vaccine. 2024;45:126587.
    PubMed         Abstract available

  70. KARACHALIOU M, Espinosa A, Farre X, Blay N, et al
    Mental illness and antibody responses after COVID-19 vaccination in a prospective population-based study in Catalonia.
    Vaccine. 2024;45:126591.
    PubMed         Abstract available

  71. SLAMANIG S, Lemus N, Lai TY, Singh G, et al
    A single immunization with intranasal Newcastle disease virus (NDV)-based XBB.1.5 variant vaccine reduces disease and transmission in animals against matched-variant challenge.
    Vaccine. 2024;45:126586.
    PubMed         Abstract available

  72. ENDER E, Joshi A, Snyder M, Kumar S, et al
    Seroconversion following PPSV23 vaccination in children with type 1 diabetes mellitus.
    Vaccine. 2024;45:126592.
    PubMed         Abstract available

  73. MASSEY PM, Murray RM, Kostizak K, Lo WJ, et al
    Exploring the ethics of using fictional stories for health education on social media to share information and emotions about the HPV vaccine: A cross-sectional study with interdisciplinary health experts.
    Vaccine. 2024 Dec 10:126575. doi: 10.1016/j.vaccine.2024.126575.
    PubMed         Abstract available

  74. ESKENAZI B, Rauch S, Elsiwi B, Bornman R, et al
    Undernutrition and antibody response to measles, tetanus and Haemophilus Influenzae type b (Hib) vaccination in pre-school south African children: The VHEMBE birth cohort study.
    Vaccine. 2024 Dec 7:126564. doi: 10.1016/j.vaccine.2024.126564.
    PubMed         Abstract available

  75. HOMSI MR, Davey-Rothwell MA, Alonge O, Caniza MA, et al
    Knowledge, attitudes, and practices of healthcare providers regarding vaccinating children with cancer in Latin America and the Caribbean.
    Vaccine. 2024;45:126578.
    PubMed         Abstract available

  76. MASEMOLA NM, Burnett RJ, Makamba-Mutevedzi PC, Schonfeldt M, et al
    Vaccine stock-outs: A preventable health facility obstacle contributing to missed vaccinations in South African children.
    Vaccine. 2024;45:126583.
    PubMed         Abstract available

  77. BODY A, Lal L, Srihari S, MacIntyre CR, et al
    Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer.
    Vaccine. 2024 Dec 7:126547. doi: 10.1016/j.vaccine.2024.126547.
    PubMed         Abstract available

  78. DE LIMA EDS, Antunes MOB, de Souza JS, Jones MH, et al
    Effectiveness of BNT162b2 and CoronaVac against COVID-19-related severe outcomes among children and adolescents: A Brazilian nationwide cohort study.
    Vaccine. 2025;44:126550.
    PubMed         Abstract available

  79. LI Y, Chen L, Xiao J, Feng K, et al
    Immunoprotective efficacy of Escherichia coli-derived outer membrane vesicles displaying PlpE protein of Pasteurella multocida.
    Vaccine. 2025;44:126532.
    PubMed         Abstract available

  80. HARTEVELD LM, van Leeuwen LM, Euser SM, Smit LJ, et al
    Respiratory syncytial virus (RSV) prevention: Perception and willingness of expectant parents in the Netherlands.
    Vaccine. 2025;44:126541.
    PubMed         Abstract available

  81. OLIVERO-DEIBE N, Frigini EN, Ramos N, Carrion F, et al
    The stability of PCV2 virus-like particles from mammalian cells and challenges for biotechnological applications.
    Vaccine. 2025;44:126549.
    PubMed         Abstract available

  82. CARNEIRO GB, Yerneni SS, Chinaia K, Araujo AP, et al
    Protection induced by Streptococcus pneumoniae extracellular vesicles against nasal colonization and invasive infection in mice and the role of PspA.
    Vaccine. 2025;44:126566.
    PubMed         Abstract available

  83. GRIGAS J, Spancerniene U, Simanavicius M, Pautienius A, et al
    Adaptive immune response to a wild boar-derived recombinant hepatitis e virus capsid protein challenge in pigs.
    Vaccine. 2024 Nov 30:126561. doi: 10.1016/j.vaccine.2024.126561.
    PubMed         Abstract available

  84. FILIMONOVIC J, Stosic M, Gazibara T, Dotlic J, et al
    The trend in national childhood immunization program coverage throughout Serbian communities in Kosovo and Metohija from 2003 to 2022: pre-COVID-19 period vs. COVID-19 pandemic.
    Vaccine. 2025;44:126576.
    PubMed         Abstract available

  85. MARCHESE AM, Beyhaghi H, Rousculp MD, Huang V, et al
    Local and systemic reactogenicity after mRNA and protein-based COVID-19 vaccines compared to meningococcal vaccine (MenACWY) in a UK blinded, randomized phase 2 trial (COV-BOOST).
    Vaccine. 2025;44:126569.
    PubMed         Abstract available

  86. ESCABI-WOJNA E, Alvelo-Fernandez PM, Suarez E, Colon-Lopez V, et al
    Sex differences in parental reasons for lack of intent to initiate HPV vaccination among adolescents ages 13-17 years: National Immunization Survey - Teen 2019-2021.
    Vaccine. 2025;44:126584.
    PubMed         Abstract available

  87. KAPLAN BS, Souza CK, Kimble JB, Brand MW, et al
    A neuraminidase-based inactivated influenza virus vaccine significantly reduced virus replication and pathology following homologous challenge in swine.
    Vaccine. 2024 Dec 6:126574. doi: 10.1016/j.vaccine.2024.126574.
    PubMed         Abstract available

  88. SANKAR C, Meyer JC, Schonfeldt M, Gunter H, et al
    Vaccine safety surveillance in South Africa through COVID-19: A journey to systems strengthening.
    Vaccine. 2024 Dec 6:126535. doi: 10.1016/j.vaccine.2024.126535.
    PubMed         Abstract available

  89. ROSENTHAL M, Stoecker C, Leidner AJ, Cho BH, et al
    Cost-effectiveness of 15-valent or 20-valent pneumococcal conjugate vaccine for U.S. adults aged 65 years and older and adults 19 years and older with underlying conditions.
    Vaccine. 2025;44:126567.
    PubMed         Abstract available

  90. CUNNINGHAM-ERVES J, Sanderson M, Jin SW, Davis J, et al
    Predictors of HPV vaccination coverage among adolescents in Tennessee during the COVID-19 pandemic: A cross-sectional study.
    Vaccine. 2024 Dec 7:126581. doi: 10.1016/j.vaccine.2024.126581.
    PubMed         Abstract available


    Virology

  91. CARCHMAN E, Sanger CB
    Anal cancer prevention: A field in need of scientific Advancement.
    Virology. 2024;602:110323.
    PubMed         Abstract available

  92. HU W, Tang D, Zeng Z, Wang B, et al
    Research progress on the molecular mechanism of immune escape of porcine reproductive and respiratory syndrome virus.
    Virology. 2025;602:110298.
    PubMed         Abstract available


    Virus Res

  93. LU H, Shao J, Liu W, Gao S, et al
    Screening and identification of linear B-cell epitopes on structural proteins of African Swine Fever Virus.
    Virus Res. 2024;350:199465.
    PubMed         Abstract available

  94. GIRMA A
    Biology of human respiratory syncytial virus: Current perspectives in immune response and mechanisms against the virus.
    Virus Res. 2024;350:199483.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.